Posted by Bob on July 12, 2010, at 16:30:09
I'm always seeing advertisements for Otsuka and Bristol-Myers Squibb's Abilify indicating it as an augmentation to the popular SSRI/SNRI antidepressants. Why don't I see similar indications for Janssen's Risperdal? Has Abilify proven more effective as an adjunct in this regard than Risperdal? Is one of them easier to tolerate than the other?
-Bob
poster:Bob
thread:954239
URL: http://www.dr-bob.org/babble/20100709/msgs/954239.html